Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of STC007 injection for postoperative pain after hip replacement surgery
CTR20261366Phase 2Active
- Sponsor
- Chengdu Nuoshengtai Biotechnology
- Start
- Apr 2026
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine liposome in postoperative pain, sponsored by Chengdu Nuoshengtai Biotechnology. Started Apr 2026; status: active.
02
Drugs
bupivacaine liposome
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20261366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261366.